These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6992490)

  • 1. Pancreatic glucagon response to glucose in hyperlipoproteinaemia with and without abnormalities in carbohydrate metabolism.
    Ratzmann KP; Schulz B; Witt S; Ziegler M; Heinke P
    Acta Endocrinol (Copenh); 1980 May; 94(1):76-83. PubMed ID: 6992490
    [No Abstract]   [Full Text] [Related]  

  • 2. A report on a case of association of diabetes mellitus and hyperthyroidism with no deterioration of diabetic control-with special regard to serial changes in glucose tolerance and glucoregulatory hormones.
    Yamaguchi K; Fukushima H; Uzawa H
    Fukuoka Igaku Zasshi; 1982 May; 73(5):272-80. PubMed ID: 6751968
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin response to glucagon. The opposing effects of diabetes and obesity.
    Crockford PM; Hazzard WR; Williams RH
    Diabetes; 1969 Apr; 18(4):216-24. PubMed ID: 5776458
    [No Abstract]   [Full Text] [Related]  

  • 4. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.
    Savage PJ; Bennion LJ; Flock EV; Nagulesparan M; Mott D; Roth J; Unger RH; Bennett PH
    J Clin Endocrinol Metab; 1979 Jun; 48(6):999-1007. PubMed ID: 447806
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of islet-cell function in man.
    Arky RA; Knopp RH
    N Engl J Med; 1971 Nov; 285(20):1130-1. PubMed ID: 4937863
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of pancreatic glucagon secretion during a continuous glucose infusion in early and overt diabetics.
    Schulz B; Ziegler M; Witt S; Rjasanowski I; Heinke P; Bibergeil H
    Acta Endocrinol (Copenh); 1978 Oct; 89(2):329-38. PubMed ID: 696182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pancreatic hormone secretion in patients with newly detected diabetes mellitus].
    Belovalova IM; Kniazeva AP; Starosel'tseva LK; Perelygina AA
    Probl Endokrinol (Mosk); 1988; 34(6):3-6. PubMed ID: 3070538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of glucagon metabolism in untreated diabetes mellitus.
    Buchanan KD; McCarroll AM
    Lancet; 1972 Dec; 2(7792):1394-5. PubMed ID: 4118687
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin, growth hormone, and glucagon in prediabetes mellitus--a review.
    Johansen K; Soeldner JS; Gleason RE
    Metabolism; 1974 Dec; 23(12):1185-99. PubMed ID: 4610319
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma.
    Schwarts SS; Zeidler A; Moossa AR; Kuku SF; Rubenstein AH
    Am J Dig Dis; 1978 Dec; 23(12):1107-14. PubMed ID: 367155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucagon secretion in hyperlipoproteinemia and adiposity].
    Ratzmann KP
    Z Gesamte Inn Med; 1982 Apr; 37(8):225-8. PubMed ID: 7113310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin response to glucagon: effects of diabetes and obesity on nonglucose-dependent insulin secretion.
    Hazzard WR; Crockford PM; Williams RH
    Diabetes; 1968; 17():297. PubMed ID: 5651714
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamics of insulin and glucagon secretions in severely burned patients.
    Shuck JM; Eaton P; Shuck LW; Wachtel TL; Schade DS
    J Trauma; 1977 Sep; 17(9):706-13. PubMed ID: 894760
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of glucagon in the etiopathogenesis and physiopathology of diabetes mellitus and obesity].
    Mincu I; Ionescu-Tirgovişte C; Baboia D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1974; 26(8):893-904. PubMed ID: 4157094
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of ponderal on the state of carbohydrate metabolism and insulin secretion in type 2 diabetes mellitus].
    Balabolkin MI; Novikova OM; Levitskaia ZI
    Sov Med; 1991; (11):56-9. PubMed ID: 1767320
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma insulin and glucose profiles in normal, obese, and diabetic persons.
    Genuth SM
    Ann Intern Med; 1973 Dec; 79(6):812-22. PubMed ID: 4761908
    [No Abstract]   [Full Text] [Related]  

  • 18. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
    Herman WH; Fajans SS; Smith MJ; Polonsky KS; Bell GI; Halter JB
    Diabetes; 1997 Nov; 46(11):1749-54. PubMed ID: 9356021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-glucagon substrate interrelationships in the neonatal sheep.
    Fiser RH; Phelps DL; Williams PR; Sperling MA; Fisher DA; Oh W
    Am J Obstet Gynecol; 1974 Dec; 120(7):944-50. PubMed ID: 4611217
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of gastrin in regulating insulin and glucagon secretion in patients with diabetes mellitus].
    Starosel'tseva LK; Kniazeva AP; Belovalova IM; Abduraimova GR
    Probl Endokrinol (Mosk); 1988; 34(4):20-5. PubMed ID: 3057484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.